Simultaneous dual minimally invasive surgery (TAVI+McKeown) for esophageal cancer with severe aortic regurgitation_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

CHENG Liang ¹ , LIU Lulu ² , XIAO Xin ¹ , LIN Lin ¹ , YANG Mei ¹ , FAN Jingxiu ³ , YU Hai ⁴ , CHEN Longqi ¹ ,  GUO Yingqiang ² ,  YUAN Yong ¹

1. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
2. Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
3. Cardiothoracic Intensive Care Unit, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
4. Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;

Corresponding author：

GUO Yingqiang, Email: drguoyq@hotmail.com; YUAN Yong, Email: yongyuan@scu.edu.com

Keywords：

Esophageal cancer; aortic regurgitation; minimally invasive surgery

DOI：

10.7507/1007-4848.202303053

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The patient is a 71-year-old male with esophageal cancer and aortic vavle regurgitation. At present, the treatment strategy of such patients is controversial. For the elderly patients with esophageal cancer who do not need neoadjuvant treatment, considering the risk of cardiopulmonary bypass and the potential risk of esophageal cancer metastasis, we have successfully implemented apical catheter aortic valve implantation and minimally invasive three-incision thoracolaparoscopy combined with radical resection of esophageal cancer (McKeown) at the same period.

1.	Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
2.	Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J, 2022, 43(39): 3826-3924.
3.	Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 2003, 24(13): 1231-1243.
4.	Chaliki HP, Mohty D, Avierinos JF, et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation, 2002, 106(21): 2687-2693.
5.	Liu L, Chen S, Shi J, et al. Transcatheter aortic valve replacement in aortic regurgitation. Ann Thorac Surg, 2020, 110(6): 1959-1965.
6.	Liu L, Yao X, Peng Y, et al. One-year outcome after transcatheter aortic valve replacement for aortic regurgitation: A single-center study. J Card Surg, 2022, 37(4): 882-892.
7.	中华人民共和国国家卫生健康委员会医政医管局. 食管癌诊疗指南(2022年版). 中华消化外科杂志, 2022, 21(10): 1247-1268.
8.	Sakai T, Yahagi K, Miura S, et al. Transcatheter aortic valve implantation for patients with lung cancer and aortic valve stenosis. J Thorac Dis, 2018, 10(5): E387-E390.
9.	Komatsu H, Izumi N, Tsukioka T, et al. Pulmonary resection for lung cancer following transcatheter aortic valve implantation for severe aortic valve stenosis: A case report. Ann Thorac Cardiovasc Surg, 2020, 26(4): 220-223.
10.	Xu H, Tao T, Ma L, et al. Concomitant surgery for aortic valve and lung cancer patients in an elder. J Cardiothorac Surg, 2020, 15(1): 257.

1. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
2. Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J, 2022, 43(39): 3826-3924.
3. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 2003, 24(13): 1231-1243.
4. Chaliki HP, Mohty D, Avierinos JF, et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation, 2002, 106(21): 2687-2693.
5. Liu L, Chen S, Shi J, et al. Transcatheter aortic valve replacement in aortic regurgitation. Ann Thorac Surg, 2020, 110(6): 1959-1965.
6. Liu L, Yao X, Peng Y, et al. One-year outcome after transcatheter aortic valve replacement for aortic regurgitation: A single-center study. J Card Surg, 2022, 37(4): 882-892.
7. 中华人民共和国国家卫生健康委员会医政医管局. 食管癌诊疗指南(2022年版). 中华消化外科杂志, 2022, 21(10): 1247-1268.
8. Sakai T, Yahagi K, Miura S, et al. Transcatheter aortic valve implantation for patients with lung cancer and aortic valve stenosis. J Thorac Dis, 2018, 10(5): E387-E390.
9. Komatsu H, Izumi N, Tsukioka T, et al. Pulmonary resection for lung cancer following transcatheter aortic valve implantation for severe aortic valve stenosis: A case report. Ann Thorac Cardiovasc Surg, 2020, 26(4): 220-223.
10. Xu H, Tao T, Ma L, et al. Concomitant surgery for aortic valve and lung cancer patients in an elder. J Cardiothorac Surg, 2020, 15(1): 257.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Latest ArticlesSimultaneous dual minimally invasive surgery (TAVI+McKeown) for esophageal cancer with severe aortic regurgitation

Abstract Full text Figures/Tables Video References Cited by

Format

Content